FACSVantage after labeling with FITC anti-CD34 and phycoerythrin anti-CD19 mAb's (Beckman Coulter, Brea, California, USA).
RNA and RT-PCR. Total RNA was extracted from 10 4 -10 5 purified cells using TRIzol Reagent (Life Technologies Inc., Rockville, Maryland, USA). RNA was reverse transcribed with Superscript II (Life Technologies Inc.) according to the manufacturer's instructions. For RT-PCR reactions, cDNA was amplified for 25 (actin), 35 (V H -C µ ), or 38 (V κ -C κ ) cycles of 30 seconds at 94°C, 30 seconds at 60°C, and 30 seconds at 72°C, or for 40 cycles (V λ -C λ ) of 30 seconds at 94°C, 30 seconds at 55°C, and 30 seconds at 72°C, with a final 10-minute extension at 72°C using Hot Star Taq DNA polymerase (QIAGEN Inc., Valencia, California, USA) and the following primers: V λ consensus sense, 5′GGG(G/A)TC(T/C)CT-GA(C/T/G)CG(A/C/G)TTCTCTGG(C/G)TCC3′; C λ antisense, 5′CACAC(T/C)AGTGTGGCCTTGTTGGCTTG3′. V H 1, V H 3, V H 4, C µ , V κ consensus and C κ primers were described previously (48, 49) . RT-PCR products were analyzed on 2% agarose gels and visualized by adding 0.3 pmol of 32 PdATP to the PCR reaction.
Cloning and sequencing. PCR products were gel-purified (Qiaquick; QIAGEN Inc.) and cloned into TA vectors (Invitrogen, Carlsbad, California, USA). Doublestranded DNA sequences were obtained using antisense C µ , C κ , or C λ primers and Dye Terminator Cycle Sequencing (Applied Biosystems, Foster City, California, USA). Sequences were analyzed by comparison with Ig basic alignment search tool (BLAST). IgH CDR3 length was determined by counting amino acid residues between positions 94 and 102 (conserved tryptophan in all J H segments) and D segments were identified following the criteria of Corbett et al. (50) . Igκ and Igλ CDR3 length included amino acids between conserved cystein 88 and the phenylalanine residue embedded in J κ or J λ (51) . Nontemplate (N) nucleotides (52) found at V κ -J κ or V λ -J λ junctions were counted while template-dependent palindromic (P) nucleotides (53) were excluded. Differences in gene distribution were analyzed with χ 2 tests (Cochran-Mantel-Haenszel test) adjusted by the Bonferroni method for multiple testing, and they were considered significant when P values were less than or equal to 0.05.
Results

IgH and IgL transcription is independent of Igµ expression.
Two patients with agammaglobulinemia and IgH mutations were studied. Igµ -/-has a cytidine insertion in the CH1 exon of the Igµ gene that leads to a frameshift and the inability to produce Igµ products (13, 46, 47) . Igµ ∆ has a deletion in the Ig locus from 3′ of the diversity (D) region to Igγ2, with all junction (J) segments and Igµ, Igδ, Igγ3, and Igγ1 genes missing (C. Schiff, unpublished observations).
Flow cytometric analysis of bone marrow from Igµ -/-and Igµ ∆ patients revealed that in both cases B cell differentiation was arrested at the CD34 + CD19 + pro-B cell stage (Figure 1a) (12, 13, 46, 47) . To characterize Ig expression in Igµ-deficient pro-B cells, transcripts for heavy and light chain genes were amplified by semiquantitative RT-PCR from sorted CD34 + CD19 + pro-B cells from Igµ -/-, Igµ ∆ , and a control sibling (Figure 1 ). As expected, V H -C µ mRNA was missing in Igµ ∆ pro-B cells where the entire Igµ locus was deleted (Figure 1b) . In contrast, Igµ -/-and control pro-B cells showed similar levels of V H -C µ transcripts revealing that the absence of Igµ protein does not affect the Igµ gene expression in humans (Figure 1b) .
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The Light chain gene transcripts were found at similar levels in sorted control or Igµ-deficient pro-B cells (Figure 1b ), but they were not amplified from Igµ -/-total bone marrow cells that contain few pro-B cells (46, 47 (20) . In contrast, two-thirds of IgH CDR3s were found to be in-frame in control CD34 + CD19 + precursor cells, suggesting early Igµ-mediated positive selection of a subpopulation of CD34 + CD19 + cells that express Igµ (Table 1) . We compared IgH genes expressed by Igµ -/-pro-B cells to the in-frame IgH genes expressed by control CD34 + CD19 + cells and found an average CDR3 length of 16.0 and 16.5 amino acids, respectively, whereas peripheral B cells showed an average CDR3 length of 13.5 amino acids (Figure 2a ). D-D fusions that increase the length of CDR3 were found in about 2% (4 of 198) of the IgH sequences from Igµ -/-pro-B cells and in 2.6% (3 of 117) of those from control CD34 + CD19 + cells, but were absent in peripheral B cells (49, 50) (data not shown). We conclude that IgH CDR3 length is not selected in early B cell precursors and that long CDR3s and D-D fusions are counterselected during late stages of B cell development. D segments can be used in three different reading frames, but in humans, RF1 tends to encode stop codons, RF2 usually encodes glycine residues, and hydrophilic amino acids and RF3 is biased to encode hydrophobic sequences (50) . D segments in RF1 are Igκ CDR3 analysis revealed that the ratio of productive to nonproductive V κ -J κ joints in human pro-B cells was similar to that reported for mIgµ-deficient mouse (µMT) pro-B cells (54) . Igκ CDR3 length was increased in all pro-B cell samples when compared with peripheral B cells (Table 1 and Figure 4a ). We found that Igκ CDR3s from control pro-B cells and from the patients had an average of 10.2, 11.2, or 11.1 amino acids where-
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The as Igκ CDR3 from peripheral B cells were only 9.0 amino acids long (Figure 4a ). The increased CDR3 length in pro-B cells was due to terminal deoxynucleotidyl transferase-catalyzed (TdT-catalyzed) addition of template-independent (N) nucleotides and not to template-dependent P nucleotides (Figure 4b ). On average, 3.6, 7.3, and 6. Igλ genes expressed in control, Igµ -/-, and Igµ ∆ pro-B cells resembled Igκ genes in that they showed a similar ratio of in-frame and out-of-frame sequences and long CDR3s, resulting from addition of N nucleotides by TdT ( Figure 6 , a and b, and Table 1 ). The average number of N nucleotides in Igλ CDR3s from control, Igµ -/-, and Igµ ∆ pro-B cells was 3.9, 5.0, and 6.5 as compared with 1.2 for mature B cells (Figure 6b) . We conclude that the Igλ genes expressed by Igµ -/-and Igµ ∆ pro-B cells differ from Igκ genes in that they show no signs of secondary recombination, but they resemble Igκ genes in that they display long CDR3s with extensive N addition.
Discussion
The absence of Igµ in Igµ -/-and Igµ ∆ patients provided an opportunity to study the role of Igµ in selecting the Ab repertoire in humans. We found no significant differences in the Ig heavy chain gene V H , D, or J H repertoire between Ig-deficient pro-B cells, control pro-B cells, and normal peripheral B cells. These findings are in agreement with cell-sorting experiments in which normal pro-B, pre-B, and immature B cell repertoires were compared with that of peripheral B cells (19) (20) (21) 31) . Thus, V H , D, and J H segment usage in humans is independent of Igµ expression and is likely to be a function of intrinsic genetic elements controlling V H , D, or J H gene accessibility and recombination. In contrast, IgH CDR3 length appears to be selected throughout B cell development starting with CD34 -CD19 + IgM -pre-B cells (33) . Our analysis of Igµ -/-and control CD34 + CD19 + cells showed that Igµ expression is not involved in IgH CDR3 length and hydrophilic RF selection in the human at the pro-B cell stage. However, in-frame IgH genes without stop codons were enriched in control CD34 + CD19 + B cell progenitors, suggesting that an efficient selection process driven by pre-BCRs operates in normal CD34 + CD19 + B cell precursors. These Igµ-positive B cell precursors displaying surface pro-B cell markers are likely to be in transition to the pre-B cell stage and equivalent to the mouse C′ early pre-B cell fraction of Hardy's classification (58) . By analogy to Igµ or Igβ knockout mice, the C′ early pre-B cell fraction is missing in Igµ -/-CD34 + CD19 + precursor B cells and results in a decrease of in-frame Igµ rearrangements when compared with normal CD34 + CD19 + precursor B cells (10, 59) .
In the mouse, ψL has been implicated in IgH repertoire selection by virtue of pairing with some but not all V H domains (16, 18) . Analysis of the V H repertoire in λ5 -/-mice showed that the normal repertoire shift seen between the pro-B and the pre-B cell stage was absent (16) . However, differences in pairing efficiency between ψL and IgH are not likely to influence the selection against long or hydrophobic CDR3s in humans because these features are prevalent in control CD34 + CD19 + cells, in immature B cells that have passed ψL selection, and in B cells that express ψLs in the periphery (31, 49) . A more likely explanation for selection against long and hydrophobic IgH CDR3s is that these features are associated with self-reactivity and might also interfere directly with IgH and IgL pairing (31, 49, 60, 61) . Immature B cells displaying such Ab's therefore would be silenced by deletion or receptor editing, or alternatively, would fail to be positively selected in the mature B cell compartment (39, 40, (42) (43) (44) (62) (63) (64) .
In the mouse, two Igµ-mediated mechanisms account for selection against self-reactive or poorly pairing Ab's during B cell development, receptor editing and deletion (39) (40) (41) (42) (43) (44) . Editing makes a major contribution to the Ab repertoire in mice: up to 25% of all Ab's are produced by editing, but the role of deletion in repertoire selection is not known (65) . Our experiments suggest that Igµ-mediated selection also makes a large contribution to shaping the human Ab repertoire. The selection against IgHs with long or hydrophobic CDR3s found in pro-B cells would require loss of at least 20-25% of all heavy chains.
In both mouse and human B cells, V(D)J recombination is generally ordered, starting with IgH rearrangement in pro-B cells followed by IgL rearrangement in pre-B cells (66, 67) . However, analysis of mouse Igµ mutants and normal pro-B cells showed that IgL genes can recombine before IgH in pro-B cells (54, (68) (69) (70) (71) . Our experiments show that human control and Igµ-deficient pro-B cells are similar to their mouse counterparts in that they undergo Igκ and Igλ gene rearrangements. These results are in agreement with the finding of rare IgL chain gene recombination in normal human pro-B cells and in Epstein-Barr virus-transformed fetal B cell precursors (67, 72) . Thus, IgL rearrangement in the human is similar to the mouse in that it is not strictly dependent on Igµ expression or pre-B cell development.
Up to 50% of human light chains in normal peripheral B cells show N nucleotide addition, but Igκ or Igλ CDR3s are never as long as 11 or 13 amino acids, respectively (49, (73) (74) (75) (76) . Igκ or Igλ genes found in control and Igµ-deficient pro-B cells differ from those found in normal peripheral B cells in that they show extensive N nucleotide addition associated with long IgL CDR3s that can reach up to 21 amino acids. Thus, long IgL CDR3s are produced in early developing B cells but they appear to be incompatible with B cell development and are deleted from the mature peripheral B cell repertoire.
Igµ-deficient pro-B cells express Igκ genes that display a bias to 3′ Jκs and 5′ Vκs consistent with persistent V(D)J recombination. However, the bias to 3′ Jκs was incomplete since there was no significant increase in Jκ5, the most downstream Jκ segment. In addition, there was no bias to downstream Jλs despite a genomic configuration that allows secondary rearrangements (55, 77, 78) . We speculate that in the absence of Igµ, human pro-B cells undergo several rounds of recombination on Igκ but do not survive long enough to allow extensive secondary recombination. The absence of secondary recombination on Igλ in Igµ-deficient pro-B cells may result from a delayed recombination of this locus when compared with Igκ (79, 80) . Alternatively, secondary recombination may be less efficient for Igλ than Igκ.
Secondary Igκ recombination is prominent in Igµ-deficient pro-B cells yet not in normal control pro-B cells. Secondary recombination in Igµ-deficient pro-B cells therefore appears to be a default mechanism in the absence of Igµ expression, and termination of secondary recombination in developing B cells requires BCR signaling. We speculate that the regulation of Ig light chain gene recombination during B cell development resembles that of T cell receptor-α (TCR-α) chains during T cell development in that recombination is terminated by a yet to be determined positive selection signal transduced by the BCR (81). Developing B cells remain in the pre-B cell compartment for a few hours whereas developing T cells remain in the CD4 + CD8 + double-positive compartment for 3-4 days (65, 82, 83) . This kinetic difference may explain why Ig light chains are allelic excluded in B cells whereas TCR-α chains in T cells are not.
